Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Sirel Gurbuz, et al
Sharing a recently published set of practical recommendations by Harvard scientists for patients using highly effective GLP-1 medications
States that prohibit or severely restrict telehealth controlled-substance prescribing: States with no additional restrictions beyond federal law: For GLP-1 agonists (semaglutide, tirzepatide, liraglutide) which are not controlled substances telehealth prescribing is generally permitted in all states, provided you: Best practices for telehealth weight management: Case in point: In 2023, a Mississippi physician had his license suspended for prescribing Ozempic through an instant-messaging platform with no audio/video evaluation
If a consumer is eating less, the eating experience needs to be worth it. A reduced appetite may make it challenging to maintain adequate nutrient intake while taking GLP-1 medication, so food formulators have an opportunity to close the gap